Bizarre Patents
A simulation environment for the sport of boxing utilizing a robotic machine interface system which carries a person.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7489017 | Fixed parallel plate MEMS capacitor microsensor array A fixed parallel plate micro-mechanical systems (MEMS) based sensor is fabricated to allow a dissolved dielectric to flow through a porous top plate, coming to rest on a bottom plate. A post-deposition bake ensures further purity and uniformity of the dielectric lay... | 02/10/2009 |
| 7470420 | Optical determination of glucose utilizing boronic acid adducts The present invention concerns an improved optical method and optical sensing device for determining the levels of polyhydroxyl-substituted organic molecules in vitro and/or in vivo in aqueous media. The range of detection is between about 400 and 800 nm. In particu... | 12/30/2008 |
| 7417037 | Compositions and methods of treatment for inflammatory diseases Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn'... | 08/26/2008 |
| 7230533 | Neverlost keychain Devices for locating misplaced keys are described. Such devices include a housing in which is disposed a cell phone receiver, a ringer, associated circuitry, a power supply, and an “on/off” switch”. Such devices may also include a battery life indicator dispos... | 06/12/2007 |
| 7109299 | Peptides and compounds that bind to the IL-5 receptor Interleukin-5 receptor (IL-5R) ligands comprising amino sequences of formula TGGGDGYVX3VE X4 ARCPTCK, EGYVX3VE X4 ARCPTCK, EGYVX3VE X4 ARCPTCR, GYVX3VE X4 ARCPTCG, EGYVX3 | 09/19/2006 |
| 6958214 | Polymorphic kinase anchor proteins and nucleic acids encoding the same Polymorphic A-kinase anchor proteins (AKAPs) and nucleic acids encoding the proteins are provided herein. Methods of detecting polymorphic AKAPs and nucleic acids encoding the AKAPs, and kits for use in the detection methods are also provided. Further provided herei... | 10/25/2005 |
| 6881546 | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor Methods and compositions are disclosed that are useful for the prevention and/or treatment of cardiovascular and cardiac diseases and disorders, or damage resulting from surgical or medical procedures that may cause ischemic or ischemic/reperfusion damage in humans;... | 04/19/2005 |
| 6787154 | Artificial antigen presenting cells The present invention is directed to artificial antigen presenting cells and methods of making artificial antigen presenting cells. Such artificial antigen presenting cells may be used in certain methods of isolating and expanding T cell populations as well as modul... | 09/07/2004 |
| 6763264 | Method of treatment using electroporation mediated delivery of drugs and genes A method for in vivo electrotherapy, or electroporation-mediated therapy, using a needle array apparatus is provided. Treatment of tumors with a combination of electroporation using the apparatus of the invention, and a chemotherapeutic agent, caused regression of t... | 07/13/2004 |
| 6716811 | Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses Novel compounds are provided that bind to G-CSFR. The novel compounds have a peptide chain approximately 6 to 40 amino acids in length that binds to G-CSFR. The compounds are useful as probes for affinity screening. In addition, the compounds have demonstrated agoni... | 04/06/2004 |
| 6697669 | Skin and muscle-targeted gene therapy by pulsed electrical field The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, p... | 02/24/2004 |
| 6678556 | Electrical field therapy with reduced histopathological change in muscle In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune r... | 01/13/2004 |
